2013 Q4 Form 10-Q Financial Statement

#000119312513422661 Filed on November 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $1.245B $1.189B $870.6M
YoY Change 31.52% 36.56% 23.06%
Cost Of Revenue $1.001B $964.4M $702.4M
YoY Change 32.39% 37.3% 22.71%
Gross Profit $243.3M $227.2M $170.0M
YoY Change 28.05% 33.65% 23.46%
Gross Profit Margin 19.55% 19.11% 19.53%
Selling, General & Admin $85.70M $89.90M $84.30M
YoY Change -3.05% 6.64% 23.43%
% of Gross Profit 35.22% 39.57% 49.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.000M $3.600M $2.100M
YoY Change 73.91% 71.43% 23.53%
% of Gross Profit 1.64% 1.58% 1.24%
Operating Expenses $85.70M $89.90M $84.40M
YoY Change -3.05% 6.52% 23.75%
Operating Profit $157.6M $137.3M $85.60M
YoY Change 55.12% 60.4% 23.17%
Interest Expense -$5.800M $5.682M $1.511M
YoY Change 5.45% 276.04% -402.2%
% of Operating Profit -3.68% 4.14% 1.77%
Other Income/Expense, Net
YoY Change
Pretax Income $151.8M $131.6M $84.13M
YoY Change 58.13% 56.41% 22.11%
Income Tax $54.00M $48.66M $31.13M
% Of Pretax Income 35.57% 36.97% 37.0%
Net Earnings $97.81M $82.94M $53.00M
YoY Change 61.33% 56.48% 22.09%
Net Earnings / Revenue 7.86% 6.98% 6.09%
Basic Earnings Per Share $18.08 $10.60
Diluted Earnings Per Share $21.15 $17.67 $10.33
COMMON SHARES
Basic Shares Outstanding 4.548M shares 4.588M shares 4.999M shares
Diluted Shares Outstanding 4.695M shares 5.132M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $865.6M $811.6M $1.078B
YoY Change -24.9% -24.68% 117.06%
Cash & Equivalents $866.3M $814.2M $1.079B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $745.8M $926.9M $716.4M
Prepaid Expenses
Receivables $9.500M $13.10M $10.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.621B $1.752B $1.804B
YoY Change -12.66% -2.9% 63.0%
LONG-TERM ASSETS
Property, Plant & Equipment $37.30M $35.80M $29.30M
YoY Change 26.44% 22.18% 21.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $90.50M $78.60M
YoY Change
Other Assets $162.4M
YoY Change 11.54%
Total Long-Term Assets $865.2M $767.3M $676.8M
YoY Change 15.51% 13.37% -2.32%
TOTAL ASSETS
Total Short-Term Assets $1.621B $1.752B $1.804B
Total Long-Term Assets $865.2M $767.3M $676.8M
Total Assets $2.486B $2.519B $2.481B
YoY Change -4.56% 1.54% 37.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $203.5M $248.7M $178.5M
YoY Change 10.54% 39.33% 1.83%
Accrued Expenses $316.2M $270.8M $226.8M
YoY Change 34.67% 19.4% 11.56%
Deferred Revenue
YoY Change
Short-Term Debt $3.400M $600.0K $900.0K
YoY Change -26.09% -33.33% -84.21%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $624.1M $642.3M $501.1M
YoY Change 19.29% 28.18% 11.13%
LONG-TERM LIABILITIES
Long-Term Debt $599.1M $599.1M $599.0M
YoY Change 0.02% 0.02% 35135.29%
Other Long-Term Liabilities $1.600M $2.500M $1.400M
YoY Change -27.27% 78.57% 27.27%
Total Long-Term Liabilities $600.7M $601.6M $600.4M
YoY Change -0.08% 0.2% 21342.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $624.1M $642.3M $501.1M
Total Long-Term Liabilities $600.7M $601.6M $600.4M
Total Liabilities $1.225B $1.244B $1.101B
YoY Change 8.93% 12.93% 142.82%
SHAREHOLDERS EQUITY
Retained Earnings $4.606B $4.508B $4.278B
YoY Change 6.14% 5.36%
Common Stock $1.212B $1.209B $1.135B
YoY Change 3.62% 6.55%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.556B $4.442B $4.034B
YoY Change 13.11% 10.11%
Treasury Stock Shares $16.12M 16.01M shares 15.68M shares
Shareholders Equity $1.261B $1.275B $1.379B
YoY Change
Total Liabilities & Shareholders Equity $2.486B $2.519B $2.481B
YoY Change -4.56% 1.54% 37.85%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $97.81M $82.94M $53.00M
YoY Change 61.33% 56.48% 22.09%
Depreciation, Depletion And Amortization $4.000M $3.600M $2.100M
YoY Change 73.91% 71.43% 23.53%
Cash From Operating Activities $182.0M $178.7M $106.1M
YoY Change 111.87% 68.43% 415.05%
INVESTING ACTIVITIES
Capital Expenditures -$4.900M -$6.000M -$4.400M
YoY Change 145.0% 36.36% 266.67%
Acquisitions
YoY Change
Other Investing Activities -$11.00M $4.100M $1.400M
YoY Change -28.1% 192.86% -39.13%
Cash From Investing Activities -$15.90M -$1.900M -$3.000M
YoY Change -8.09% -36.67% -400.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -114.1M -141.0M 382.2M
YoY Change -1911.11% -136.89% -184.0%
NET CHANGE
Cash From Operating Activities 182.0M 178.7M 106.1M
Cash From Investing Activities -15.90M -1.900M -3.000M
Cash From Financing Activities -114.1M -141.0M 382.2M
Net Change In Cash 52.00M 35.80M 485.3M
YoY Change -30.57% -92.62% -211.98%
FREE CASH FLOW
Cash From Operating Activities $182.0M $178.7M $106.1M
Capital Expenditures -$4.900M -$6.000M -$4.400M
Free Cash Flow $186.9M $184.7M $110.5M
YoY Change 112.63% 67.15% 406.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
16008428 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
17741000
CY2013Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
2235000
CY2013Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
3021000
CY2013Q3 us-gaap Deposits Assets
DepositsAssets
218527000
CY2013Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
81736000
CY2013Q3 us-gaap Loans Held For Sale Mortgages
LoansHeldForSaleMortgages
153928000
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
58790000
CY2012Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
61101000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1078548000
CY2012Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
167000
CY2013Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
77341000
CY2013Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
2454000
CY2013Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0395 pure
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20555330 shares
CY2013Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0397 pure
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
1275094000
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1208653000
CY2013Q3 us-gaap Non Recourse Debt
NonRecourseDebt
559000
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4507746000
CY2013Q3 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
0
CY2013Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
600000000
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1699000
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
206000
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2518897000
CY2013Q3 us-gaap Liabilities
Liabilities
1243803000
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
17741000
CY2013Q3 us-gaap Assets
Assets
2518897000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
814197000
CY2013Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
59409000
CY2013Q3 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
9808000
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
4441511000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4339080000
CY2013Q3 nvr Number Of Raw Parcels Of Land Acquired
NumberOfRawParcelsOfLandAcquired
5 Parcels
CY2013Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
85400000
CY2013Q3 nvr Land Under Development Related To Consolidated Joint Venture
LandUnderDevelopmentRelatedToConsolidatedJointVenture
6120000
CY2013Q3 nvr Power Of Developers Equity Holders To Direct Operating Activities Of Development Entity
PowerOfDevelopersEquityHoldersToDirectOperatingActivitiesOfDevelopmentEntity
1.00 pure
CY2013Q3 nvr Finished Lots Committed To Purchase
FinishedLotsCommittedToPurchase
23 Lot
CY2013Q3 nvr Loss Reserve On Contract Land Deposits
LossReserveOnContractLandDeposits
61003000
CY2013Q3 nvr Contingent Specific Performance Obligations
ContingentSpecificPerformanceObligations
2317000
CY2013Q3 nvr Contract Land Deposits Risk Of Loss
ContractLandDepositsRiskOfLoss
223079000
CY2013Q3 nvr Other Assets Related To Consolidated Joint Venture
OtherAssetsRelatedToConsolidatedJointVenture
672000
CY2013Q3 nvr Number Of Finished Lots Intended To Be Developed From Raw Parcels Of Land
NumberOfFinishedLotsIntendedToBeDevelopedFromRawParcelsOfLand
800 Lot
CY2013Q3 nvr Number Of Joint Ventures
NumberOfJointVentures
3 Joint_Ventures
CY2013Q3 nvr Repurchase Facility Borrowing Base Limitations
RepurchaseFacilityBorrowingBaseLimitations
0
CY2013Q3 nvr Number Of Joint Ventures Company Is Not Primary Beneficiary
NumberOfJointVenturesCompanyIsNotPrimaryBeneficiary
2 Joint_Ventures
CY2013Q3 nvr Accrued Expenses Related To Consolidated Joint Venture
AccruedExpensesRelatedToConsolidatedJointVenture
852000
CY2013Q3 nvr Variable Interest Entity Consolidated Carrying Amount Liabilities And Equity
VariableInterestEntityConsolidatedCarryingAmountLiabilitiesAndEquity
9808000
CY2013Q3 nvr Equity Related To Consolidated Joint Venture
EquityRelatedToConsolidatedJointVenture
8397000
CY2013Q3 nvr Expiration Date Of Repurchase Agreement
ExpirationDateOfRepurchaseAgreement
2014-07-30
CY2013Q3 nvr Cash Related To Consolidated Joint Venture
CashRelatedToConsolidatedJointVenture
2608000
CY2013Q3 nvr Expected Production Of Finished Lots From Joint Ventures
ExpectedProductionOfFinishedLotsFromJointVentures
7300 Lot
CY2013Q3 nvr Contract Land Deposits
ContractLandDeposits
279530000
CY2013Q3 nvr Lots Controlled By Company
LotsControlledByCompany
56000 Lot
CY2013Q3 nvr Repurchase Facility Borrowing Capacity
RepurchaseFacilityBorrowingCapacity
25000000
CY2013Q3 nvr Restricted Cash Related To Consolidated Joint Venture
RestrictedCashRelatedToConsolidatedJointVenture
408000
CY2013Q3 nvr Deferred Compensation Trust Shares
DeferredCompensationTrustShares
109256 shares
CY2013Q3 nvr Fall Out Rate Of Measuring Fair Value Of Rate Lock Commitments
FallOutRateOfMeasuringFairValueOfRateLockCommitments
0.09 pure
CY2013Q3 nvr Maximum Percentage Of Deposits Required Under Purchase Agreements
MaximumPercentageOfDepositsRequiredUnderPurchaseAgreements
0.10 pure
CY2013Q3 nvr Average Basis Points Of Servicing Loan Amount
AverageBasisPointsOfServicingLoanAmount
0.0078 pure
CY2013Q3 nvr Letters Of Credit Related To Lots
LettersOfCreditRelatedToLots
2200000
CY2013Q3 nvr Cash Deposited Related To Lots
CashDepositedRelatedToLots
279500000
CY2013Q3 nvr Valuation Allowance Of Contract Land Deposit Assets
ValuationAllowanceOfContractLandDepositAssets
61000000
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4548037 shares
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
64008000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
480794000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20556198 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
15642068 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
25331000
CY2012Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3338000
CY2012Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
62742000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1480477000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1169699000
CY2012Q4 us-gaap Non Recourse Debt
NonRecourseDebt
4574000
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8778000
CY2012Q4 nvr Land Under Development Related To Consolidated Joint Venture
LandUnderDevelopmentRelatedToConsolidatedJointVenture
13382000
CY2012Q4 nvr Finished Lots Committed To Purchase
FinishedLotsCommittedToPurchase
71 Lot
CY2012Q4 nvr Loss Reserve On Contract Land Deposits
LossReserveOnContractLandDeposits
65039000
CY2012Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
893000
CY2012Q4 us-gaap Deposits Assets
DepositsAssets
191538000
CY2012Q4 us-gaap Variable Interest Entity Consolidated Carrying Amount Assets
VariableInterestEntityConsolidatedCarryingAmountAssets
15626000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4028508000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
206000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2604842000
CY2012Q4 us-gaap Liabilities
Liabilities
1124365000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Goodwill
Goodwill
441000
CY2012Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
25331000
CY2012Q4 us-gaap Assets
Assets
2604842000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1153507000
CY2012Q4 nvr Contingent Specific Performance Obligations
ContingentSpecificPerformanceObligations
7047000
CY2012Q4 nvr Contract Land Deposits Risk Of Loss
ContractLandDepositsRiskOfLoss
201923000
CY2012Q4 nvr Other Assets Related To Consolidated Joint Venture
OtherAssetsRelatedToConsolidatedJointVenture
833000
CY2012Q4 nvr Accrued Expenses Related To Consolidated Joint Venture
AccruedExpensesRelatedToConsolidatedJointVenture
935000
CY2012Q4 nvr Variable Interest Entity Consolidated Carrying Amount Liabilities And Equity
VariableInterestEntityConsolidatedCarryingAmountLiabilitiesAndEquity
15626000
CY2012Q4 nvr Equity Related To Consolidated Joint Venture
EquityRelatedToConsolidatedJointVenture
10117000
CY2012Q4 nvr Cash Related To Consolidated Joint Venture
CashRelatedToConsolidatedJointVenture
906000
CY2012Q4 nvr Contract Land Deposits
ContractLandDeposits
256577000
CY2012Q4 nvr Lots Controlled By Company
LotsControlledByCompany
53200 Lot
CY2012Q4 nvr Restricted Cash Related To Consolidated Joint Venture
RestrictedCashRelatedToConsolidatedJointVenture
505000
CY2012Q4 nvr Deferred Compensation Trust Shares
DeferredCompensationTrustShares
152223 shares
CY2012Q4 nvr Letters Of Credit Related To Lots
LettersOfCreditRelatedToLots
3300000
CY2012Q4 nvr Cash Deposited Related To Lots
CashDepositedRelatedToLots
256600000
CY2012Q4 nvr Valuation Allowance Of Contract Land Deposit Assets
ValuationAllowanceOfContractLandDepositAssets
65000000
dei Entity Registrant Name
EntityRegistrantName
NVR INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000906163
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Debt Instrument Date Of First Required Payment1
DebtInstrumentDateOfFirstRequiredPayment1
2013-03-15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
34.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.1798 pure
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4942000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
35.01
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-09-15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y2M23D
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
125000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
454782 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
271.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
88165000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3272 pure
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4817000 shares
us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
Semi-annually in arrears on March 15 and September 15
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0042 pure
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
88000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
166712 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0210 pure
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
us-gaap Interest Paid Net
InterestPaidNet
24673000
us-gaap Revenues
Revenues
2969115000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
55209000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
266876000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
43951000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
22399000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
23811000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
987000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
11000000
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales
RealEstateInventoryCapitalizedInterestCostsCostOfSales
51000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
473000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
10950000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3909000
us-gaap Net Income Loss
NetIncomeLoss
168666000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
231676000
nvr Deferred Compensation Activity
DeferredCompensationActivity
nvr Contract Land Deposit Asset Recovery
ContractLandDepositAssetRecovery
4600000
nvr Fair Value Measurements Security Price Change Included In Earnings
FairValueMeasurementsSecurityPriceChangeIncludedInEarnings
-5905000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1673257000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30385000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
435809000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
23811000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
4015000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14069000
us-gaap Interest Costs Incurred
InterestCostsIncurred
18801000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-408922000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
6135000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
435809000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4323000
us-gaap Share Based Compensation
ShareBasedCompensation
30385000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-339310000
us-gaap Interest Expense
InterestExpense
16622000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
381000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
30707000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18553000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7564000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
-4590000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9375000
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
1751736000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
23811000
us-gaap Proceeds From Collection Of Mortgage Loans Held For Sale
ProceedsFromCollectionOfMortgageLoansHeldForSale
1288000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98210000
nvr Fair Value Measurements Interest Rate Movement Effect
FairValueMeasurementsInterestRateMovementEffect
4444000
nvr Fair Value Measurement Assumed Gain Loss From Loan Sale
FairValueMeasurementAssumedGainLossFromLoanSale
-2481000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
23.22
nvr Derivative Instruments Fair Value Adjustment Gain Loss
DerivativeInstrumentsFairValueAdjustmentGainLoss
-439000
nvr Increase Decrease In Accounts Payable Customer Deposits And Accrued Expenses
IncreaseDecreaseInAccountsPayableCustomerDepositsAndAccruedExpenses
136935000
nvr Corporate Capital Allocation Charge
CorporateCapitalAllocationCharge
86588000
nvr Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties
CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties
49701000
nvr Fair Value Measurements Changes In Servicing Rights Value
FairValueMeasurementsChangesInServicingRightsValue
3503000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5167000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
23.76
nvr Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties
CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties
27587000
CY2013Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
11000000
CY2013Q1 nvr Number Of Finished Lots Intended To Be Developed From Newly Acquired Raw Parcel Of Land
NumberOfFinishedLotsIntendedToBeDevelopedFromNewlyAcquiredRawParcelOfLand
400 Lot
CY2013Q1 nvr Inventory Real Estate Land Acquisition Costs
InventoryRealEstateLandAcquisitionCosts
28500000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
118000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
178450000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5049000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
171508 shares
us-gaap Interest Paid Net
InterestPaidNet
705000
us-gaap Revenues
Revenues
2240912000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
36054000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
179046000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4024000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
33351000
us-gaap Increase Decrease In Deposits Outstanding
IncreaseDecreaseInDepositsOutstanding
41231000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5687000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
1000000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
660000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
11321000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3265000
us-gaap Net Income Loss
NetIncomeLoss
119961000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
162507000
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1423299000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
220128000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
5646000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10367000
us-gaap Interest Costs Incurred
InterestCostsIncurred
2201000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
424572000
us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
598962000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
5746000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3080000
us-gaap Share Based Compensation
ShareBasedCompensation
50136000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
597754000
us-gaap Interest Expense
InterestExpense
2034000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
353000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
30494000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5268000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48853000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
-243000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5822000
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
1579863000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5687000
us-gaap Proceeds From Collection Of Mortgage Loans Held For Sale
ProceedsFromCollectionOfMortgageLoansHeldForSale
1894000
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1528000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59085000
nvr Contract Land Deposit Asset Recovery
ContractLandDepositAssetRecovery
200000
nvr Increase Decrease In Accounts Payable Customer Deposits And Accrued Expenses
IncreaseDecreaseInAccountsPayableCustomerDepositsAndAccruedExpenses
98598000
nvr Corporate Capital Allocation Charge
CorporateCapitalAllocationCharge
66239000
CY2012Q3 nvr Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties
CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties
11870000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
17.67
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4695000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
18.08
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
107000 shares
CY2013Q2 nvr Warranty Reserve Provision Single Completed Community
WarrantyReserveProvisionSingleCompletedCommunity
15600000
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
10.33
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5132000 shares
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
10.60
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
133000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4999000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
153306 shares
CY2012Q3 us-gaap Revenues
Revenues
870637000
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
84133000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
53000000
CY2012Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
1678000
CY2012Q3 us-gaap Share Based Compensation
ShareBasedCompensation
16963000
CY2012Q3 us-gaap Interest Expense
InterestExpense
1511000
CY2012Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
9559000
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31133000
CY2012Q3 nvr Contract Land Deposit Asset Impairment Charges
ContractLandDepositAssetImpairmentCharges
900000
CY2012Q3 nvr Corporate Capital Allocation Charge
CorporateCapitalAllocationCharge
24712000
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4588000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
179712 shares
CY2013Q3 us-gaap Revenues
Revenues
1188967000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
131590000
CY2013Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales
RealEstateInventoryCapitalizedInterestCostsCostOfSales
38000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
82935000
CY2013Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
6287000
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
11733000
CY2013Q3 us-gaap Interest Expense
InterestExpense
5682000
CY2013Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
11403000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48655000
CY2013Q3 nvr Contract Land Deposit Asset Recovery
ContractLandDepositAssetRecovery
600000
CY2013Q3 nvr Corporate Capital Allocation Charge
CorporateCapitalAllocationCharge
31297000
CY2013Q3 nvr Costs Accrued For New Warranty Contracts And Changes In Estimates For Pre Existing Warranties
CostsAccruedForNewWarrantyContractsAndChangesInEstimatesForPreExistingWarranties
15798000

Files In Submission

Name View Source Status
0001193125-13-422661-index-headers.html Edgar Link pending
0001193125-13-422661-index.html Edgar Link pending
0001193125-13-422661.txt Edgar Link pending
0001193125-13-422661-xbrl.zip Edgar Link pending
d596426d10q.htm Edgar Link pending
d596426dex311.htm Edgar Link pending
d596426dex312.htm Edgar Link pending
d596426dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
nvr-20130930.xml Edgar Link completed
nvr-20130930.xsd Edgar Link pending
nvr-20130930_cal.xml Edgar Link unprocessable
nvr-20130930_def.xml Edgar Link unprocessable
nvr-20130930_lab.xml Edgar Link unprocessable
nvr-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending